Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1

Jinlan Jiang, Eduardo C. Salido, Chandan Guha, Xia Wang, Rituparna Moitra, Laibin Liu, Jayanta Roy-Chowdhury, Namita Roy-Chowdhury

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

BACKGROUND. Primary hyperoxaluria type-1 (PH1) is an autosomal recessive disease characterized by excessive oxalate production by hepatocytes caused by the deficiency of peroxisomal alanine-glyoxylate aminotransferase (AGT) activity. Persistent hyperoxaluria causes nephrocalcinosis and urolithiasis, leading to renal failure, followed by tissue oxalosis with life-threatening complications. Combined liver-kidney transplantation is the only definitive treatment of PH1. Hepatocyte transplantation, which is much less invasive, could have offered an attractive alternative. However, because the AGT-deficient hepatocytes overproduce oxalate, a large fraction of the mutant host hepatocytes must be replaced by AGT-competent cells, which is beyond the capacity of current hepatocyte transplantation procedures. Here, we have evaluated a preparative irradiation-based method of liver repopulation in an Agxt-deleted mouse model of PH1 (Agxt). MATERIALS AND METHODS. Hepatocytes (10 viable cells) isolated from congeneic mice ([ROSA]26 C57BL/6J) expressing Escherichia coli β-galactosidase were transplanted into Agxt mice by intrasplenic injection. The preparative regimen consisted of X-irradiation of the host liver and mitotic stimulation of the hepatocytes by adenovector-based expression of hepatocyte growth factor. RESULTS. The procedure resulted in progressive replacement of the mutant host hepatocytes with the AGT-competent hepatocytes, leading to correction of urinary oxalate excretion. Oral ethylene glycol challenge (0.7% for 1 week) resulted in nephrocalcinosis and microlithiasis in untreated Agxt mice, but not in the mice after hepatic repopulation. CONCLUSION. The results indicate that hepatocyte transplantation after appropriate preparative regimens may permit sufficient repopulation of the liver to ameliorate hyperoxaluria, and therefore should be evaluated further as a potential treatment of PH1.

Original languageEnglish (US)
Pages (from-to)1253-1260
Number of pages8
JournalTransplantation
Volume85
Issue number9
DOIs
StatePublished - May 2008

Fingerprint

Hyperoxaluria
Hepatocytes
Liver
Oxalates
Nephrocalcinosis
Transplantation
Primary hyperoxaluria type 1
Galactosidases
Congenic Mice
Urolithiasis
Hepatocyte Growth Factor
Ethylene Glycol
Liver Transplantation
Kidney Transplantation
Renal Insufficiency

Keywords

  • Adenovirus
  • Hepatic growth factor
  • Nephrocalcinosis
  • Preparative irradiation
  • Primary hyperoxaluria type-1

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1. / Jiang, Jinlan; Salido, Eduardo C.; Guha, Chandan; Wang, Xia; Moitra, Rituparna; Liu, Laibin; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita.

In: Transplantation, Vol. 85, No. 9, 05.2008, p. 1253-1260.

Research output: Contribution to journalArticle

Jiang, Jinlan ; Salido, Eduardo C. ; Guha, Chandan ; Wang, Xia ; Moitra, Rituparna ; Liu, Laibin ; Roy-Chowdhury, Jayanta ; Roy-Chowdhury, Namita. / Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1. In: Transplantation. 2008 ; Vol. 85, No. 9. pp. 1253-1260.
@article{d0d3efed49ba423d938c07891390332c,
title = "Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1",
abstract = "BACKGROUND. Primary hyperoxaluria type-1 (PH1) is an autosomal recessive disease characterized by excessive oxalate production by hepatocytes caused by the deficiency of peroxisomal alanine-glyoxylate aminotransferase (AGT) activity. Persistent hyperoxaluria causes nephrocalcinosis and urolithiasis, leading to renal failure, followed by tissue oxalosis with life-threatening complications. Combined liver-kidney transplantation is the only definitive treatment of PH1. Hepatocyte transplantation, which is much less invasive, could have offered an attractive alternative. However, because the AGT-deficient hepatocytes overproduce oxalate, a large fraction of the mutant host hepatocytes must be replaced by AGT-competent cells, which is beyond the capacity of current hepatocyte transplantation procedures. Here, we have evaluated a preparative irradiation-based method of liver repopulation in an Agxt-deleted mouse model of PH1 (Agxt). MATERIALS AND METHODS. Hepatocytes (10 viable cells) isolated from congeneic mice ([ROSA]26 C57BL/6J) expressing Escherichia coli β-galactosidase were transplanted into Agxt mice by intrasplenic injection. The preparative regimen consisted of X-irradiation of the host liver and mitotic stimulation of the hepatocytes by adenovector-based expression of hepatocyte growth factor. RESULTS. The procedure resulted in progressive replacement of the mutant host hepatocytes with the AGT-competent hepatocytes, leading to correction of urinary oxalate excretion. Oral ethylene glycol challenge (0.7{\%} for 1 week) resulted in nephrocalcinosis and microlithiasis in untreated Agxt mice, but not in the mice after hepatic repopulation. CONCLUSION. The results indicate that hepatocyte transplantation after appropriate preparative regimens may permit sufficient repopulation of the liver to ameliorate hyperoxaluria, and therefore should be evaluated further as a potential treatment of PH1.",
keywords = "Adenovirus, Hepatic growth factor, Nephrocalcinosis, Preparative irradiation, Primary hyperoxaluria type-1",
author = "Jinlan Jiang and Salido, {Eduardo C.} and Chandan Guha and Xia Wang and Rituparna Moitra and Laibin Liu and Jayanta Roy-Chowdhury and Namita Roy-Chowdhury",
year = "2008",
month = "5",
doi = "10.1097/TP.0b013e31816de49e",
language = "English (US)",
volume = "85",
pages = "1253--1260",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1

AU - Jiang, Jinlan

AU - Salido, Eduardo C.

AU - Guha, Chandan

AU - Wang, Xia

AU - Moitra, Rituparna

AU - Liu, Laibin

AU - Roy-Chowdhury, Jayanta

AU - Roy-Chowdhury, Namita

PY - 2008/5

Y1 - 2008/5

N2 - BACKGROUND. Primary hyperoxaluria type-1 (PH1) is an autosomal recessive disease characterized by excessive oxalate production by hepatocytes caused by the deficiency of peroxisomal alanine-glyoxylate aminotransferase (AGT) activity. Persistent hyperoxaluria causes nephrocalcinosis and urolithiasis, leading to renal failure, followed by tissue oxalosis with life-threatening complications. Combined liver-kidney transplantation is the only definitive treatment of PH1. Hepatocyte transplantation, which is much less invasive, could have offered an attractive alternative. However, because the AGT-deficient hepatocytes overproduce oxalate, a large fraction of the mutant host hepatocytes must be replaced by AGT-competent cells, which is beyond the capacity of current hepatocyte transplantation procedures. Here, we have evaluated a preparative irradiation-based method of liver repopulation in an Agxt-deleted mouse model of PH1 (Agxt). MATERIALS AND METHODS. Hepatocytes (10 viable cells) isolated from congeneic mice ([ROSA]26 C57BL/6J) expressing Escherichia coli β-galactosidase were transplanted into Agxt mice by intrasplenic injection. The preparative regimen consisted of X-irradiation of the host liver and mitotic stimulation of the hepatocytes by adenovector-based expression of hepatocyte growth factor. RESULTS. The procedure resulted in progressive replacement of the mutant host hepatocytes with the AGT-competent hepatocytes, leading to correction of urinary oxalate excretion. Oral ethylene glycol challenge (0.7% for 1 week) resulted in nephrocalcinosis and microlithiasis in untreated Agxt mice, but not in the mice after hepatic repopulation. CONCLUSION. The results indicate that hepatocyte transplantation after appropriate preparative regimens may permit sufficient repopulation of the liver to ameliorate hyperoxaluria, and therefore should be evaluated further as a potential treatment of PH1.

AB - BACKGROUND. Primary hyperoxaluria type-1 (PH1) is an autosomal recessive disease characterized by excessive oxalate production by hepatocytes caused by the deficiency of peroxisomal alanine-glyoxylate aminotransferase (AGT) activity. Persistent hyperoxaluria causes nephrocalcinosis and urolithiasis, leading to renal failure, followed by tissue oxalosis with life-threatening complications. Combined liver-kidney transplantation is the only definitive treatment of PH1. Hepatocyte transplantation, which is much less invasive, could have offered an attractive alternative. However, because the AGT-deficient hepatocytes overproduce oxalate, a large fraction of the mutant host hepatocytes must be replaced by AGT-competent cells, which is beyond the capacity of current hepatocyte transplantation procedures. Here, we have evaluated a preparative irradiation-based method of liver repopulation in an Agxt-deleted mouse model of PH1 (Agxt). MATERIALS AND METHODS. Hepatocytes (10 viable cells) isolated from congeneic mice ([ROSA]26 C57BL/6J) expressing Escherichia coli β-galactosidase were transplanted into Agxt mice by intrasplenic injection. The preparative regimen consisted of X-irradiation of the host liver and mitotic stimulation of the hepatocytes by adenovector-based expression of hepatocyte growth factor. RESULTS. The procedure resulted in progressive replacement of the mutant host hepatocytes with the AGT-competent hepatocytes, leading to correction of urinary oxalate excretion. Oral ethylene glycol challenge (0.7% for 1 week) resulted in nephrocalcinosis and microlithiasis in untreated Agxt mice, but not in the mice after hepatic repopulation. CONCLUSION. The results indicate that hepatocyte transplantation after appropriate preparative regimens may permit sufficient repopulation of the liver to ameliorate hyperoxaluria, and therefore should be evaluated further as a potential treatment of PH1.

KW - Adenovirus

KW - Hepatic growth factor

KW - Nephrocalcinosis

KW - Preparative irradiation

KW - Primary hyperoxaluria type-1

UR - http://www.scopus.com/inward/record.url?scp=43449122185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449122185&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31816de49e

DO - 10.1097/TP.0b013e31816de49e

M3 - Article

VL - 85

SP - 1253

EP - 1260

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 9

ER -